Skip to main content
Billions Co.,Ltd. logo

Billions Co.,Ltd. — Investor Relations & Filings

Ticker · 044480 ISIN · KR7044480002 KO Wholesale and retail trade
Filings indexed 590 across all filing types
Latest filing 2019-01-18 Director's Dealing
Country KR South Korea
Listing KO 044480

About Billions Co.,Ltd.

http://www.unidus.co.kr

Billions Co.,Ltd. is a company with diversified operations in the entertainment and manufacturing sectors. In the entertainment field, the company is involved in artist management and the production of dramas and movies. Concurrently, its manufacturing division produces and markets latex medical products, including prophylactics, surgical gloves, and finger cots. The company has previously operated under different names, including Blade Entertainment Co Ltd and Unidus Corporation, reflecting its distinct business segments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider transactions, such as share acquisitions or disposals by directors and major shareholders. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2019-01-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement regarding shareholder records, it fits best under the RNS category.
2018-12-12 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the 3rd quarter of 2018, covering the period from January 1, 2018, to September 30, 2018. It contains detailed financial statements, management discussions, and operational information for BioGenetics Co., Ltd. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year that includes actual financial statements is classified as an Interim / Quarterly Report (IR). 9M 2018
2018-11-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose changes in significant share ownership (crossing thresholds). This falls under the 'Major Shareholding Notification' category.
2018-10-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership, changes in shareholding, and special relationships of the reporting entity (BioGenetics Investment Fund) and its special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2018-10-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.